| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3873
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38 |
| filingDate |
1996-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27a1e6b73485c26d1072e841a5c52c3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7139ae4603bf30730a5f2a8f2e960706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8732dbbf12746133dd188432a8d05aaf |
| publicationDate |
1998-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0837863-A1 |
| titleOfInvention |
Disodium alendronate formulations |
| abstract |
Disclosed is a method for treating and for preventing bone loss in patients by administering a formulation of 4-amino-1-hydroxy-butylidene-1,1-bisphophonic acid, disodium salt, or its hydrates. Also described is a pharmaceutical composition containing said disodium salt in a pharmaceutically acceptable excipient. |
| priorityDate |
1995-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |